Dr. Hamid Emamekhoo is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care. He is a medical oncologist with clinical and research focus on genitourinary malignancies. His previous research in gene targeting has evolved into an interest in a personalized approach to cancer treatment and precision oncology. He focuses on immunotherapy innovations in cancer treatment and currently serves as the principal investigator, or co-investigator, on multiple ongoing clinical trials using immunotherapy and targeted therapies in different stages of kidney, bladder and prostate cancer at UW-Madison. Dr. Emamekhoo is a member of the American Association of Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO).
Dr. Emamekhoo’s clinical interests include medical oncology with emphasis on genitourinary cancer (including bladder cancer, kidney cancer, prostate cancer, and testicular cancer).
Dr. Emamekhoo’s clinical research focuses on clinical trials of chemotherapy and/or immunotherapy treatments for genitourinary cancers.